• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.51 Down 0.02(4.32%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.54
    Open:0.53
    Bid:0.51 x 500
    Ask:0.58 x 10000
    1y Target Est:3.00
    Beta:0.57
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:0.51 - 0.54
    52wk Range:0.51 - 1.45
    Volume:640,657
    Avg Vol (3m):707,790
    Market Cap:46.20M
    P/E (ttm):N/A
    EPS (ttm):-0.16
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCDown 4.32%46.20M
    AGENUp 4.49%346.01M
    DNDN 0.00%N/A
    STMLUp 1.13%198.27M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.14
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback